Niastase
Showing 1 - 7 of 7
Intracerebral Hemorrhage Trial in Worldwide (Recombinant Activated Factor VII (rFVIIa), Placebo)
Recruiting
- Intracerebral Hemorrhage
- Recombinant Activated Factor VII (rFVIIa)
- Placebo
-
Burlingame, California
- +48 more
Jan 25, 2023
Stroke Trial in Canada (rfVIIa, Standard saline solution)
Completed
- Stroke
- rfVIIa
- Standard saline solution
-
Calgary, Alberta, Canada
- +14 more
Oct 3, 2018
Acquired Bleeding Disorder, Trauma Trial in Worldwide (activated recombinant human factor VII, )
Completed
- Acquired Bleeding Disorder
- Trauma
- activated recombinant human factor VII
- placebo
-
Perth, Australia
- +8 more
Jan 12, 2017
Acquired Bleeding Disorder, Trauma Trial in Worldwide (activated recombinant human factor VII)
Completed
- Acquired Bleeding Disorder
- Trauma
- activated recombinant human factor VII
-
Montreal, Canada
- +14 more
Jan 11, 2017
Acquired Bleeding Disorder, Intracerebral Haemorrhage Trial in Worldwide (eptacog alfa (activated))
Completed
- Acquired Bleeding Disorder
- Intracerebral Haemorrhage
- eptacog alfa (activated)
-
Birmingham, Alabama
- +166 more
Jan 11, 2017
Acquired Bleeding Disorder, Trauma Trial in Worldwide (eptacog alfa (activated), )
Terminated
- Acquired Bleeding Disorder
- Trauma
- eptacog alfa (activated)
- placebo
-
Princeton, New Jersey
- +13 more
Jun 13, 2014
Acquired Bleeding Disorder, Trauma Trial in United States (activated recombinant human factor VII)
Withdrawn
- Acquired Bleeding Disorder
- Trauma
- activated recombinant human factor VII
-
Phoenix, Arizona
- +41 more
Jun 26, 2012